Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Marcheselli · SciRah

Researcher profile · Semantic Scholar

L. Marcheselli

Share profile

L. Marcheselli — researcher profile on SciRah

h-index: 42
Works: 302
Citations: 6,574

Most-cited papers

Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
F. Merli, S. Luminari, A. Tucci, A. Arcari +41 more
2021Journal of Clinical Oncology152 citations Open access
Semantic Scholar
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
S. Luminari, M. Manni, S. Galimberti, A. Versari +29 more
2021Journal of Clinical Oncology79 citations Open access
Semantic Scholar
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
C. Visco, L. Marcheselli, Roberto Mina, M. Sassone +53 more
2021Blood Advances54 citations Open access
Semantic Scholar
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus–Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
M. Merli, S. Rattotti, M. Spina, F. Re +21 more
2022Journal of Clinical Oncology30 citations Open access
Semantic Scholar
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience
V. Zilioli, D. Albano, A. Arcari, F. Merli +10 more
2021Journal of Cachexia, Sarcopenia and Muscle28 citations Open access
Semantic Scholar
PET-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
C. Batlevi, Fushen SHA, A. Alperovich, A. Ni +21 more
2020European Journal of Cancer25 citations Open access
Semantic Scholar
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
A. Tucci, F. Merli, A. Fabbri, L. Marcheselli +26 more
2022Haematologica21 citations Open access
Semantic Scholar
BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy
A. Toss, E. Molinaro, M. Venturelli, F. Domati +10 more
2020Cancers21 citations Open access
Semantic Scholar
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
L. Arcaini, C. Bommier, J. Alderuccio, M. Merli +31 more
2024EClinicalMedicine19 citations Open access
Semantic Scholar
Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study.
G. Gini, M. Tani, A. Tucci, L. Marcheselli +22 more
2023Blood17 citations
Semantic Scholar
Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer Can Reduce the Risk of Death in Obese Women: The EMILI Study
L. Cortesi, F. Sebastiani, A. Iannone, L. Marcheselli +4 more
2020Cancers17 citations Open access
Semantic Scholar
Fertility preservation strategies for patients with lymphoma: a real-world practice survey among Fondazione Italiana Linfomi centers
S. Viviani, M. Dellino, S. Ramadan, Claudia Peracchio +3 more
2021Tumori15 citations
Semantic Scholar
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination
M. Cosenza, M. Civallero, L. Marcheselli, S. Sacchi +1 more
2020Apoptosis15 citations Open access
Semantic Scholar
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
A. Arcari, L. Rigacci, A. Tucci, Benedetta Puccini +33 more
2023Blood Advances14 citations Open access
Semantic Scholar
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
Fulvio Massaro, V. Pavone, P. Stefani, B. Botto +25 more
2021Hematological Oncology13 citations Open access
Semantic Scholar
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi
A. Arcari, Lucia Morello, D. Vallisa, L. Marcheselli +22 more
2021Leukemia and Lymphoma11 citations
Semantic Scholar
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi
M. Nizzoli, M. Manni, C. Ghiggi, A. Pulsoni +25 more
2023Hematological Oncology10 citations Open access
Semantic Scholar
The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
E. Cencini, A. Tucci, Benedetta Puccini, F. Cavallo +26 more
2022Hematological Oncology10 citations
Semantic Scholar
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
S. Bettelli, R. Marcheselli, S. Pozzi, L. Marcheselli +15 more
2021Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis10 citations Open access
Semantic Scholar
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
A. Toss, C. Piombino, E. Tenedini, A. Bologna +15 more
2021Diagnostics10 citations Open access
Semantic Scholar
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma
R. Marcheselli, A. Bari, T. Tadmor, L. Marcheselli +11 more
2020Hematological Oncology9 citations Open access
Semantic Scholar
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study
M. Cox, L. Marcheselli, Giorgia Scafetta, C. Visco +33 more
2022Leukemia8 citations Open access
Semantic Scholar
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
S. Alonso-Álvarez, M. Manni, S. Montoto, C. Sarkozy +17 more
2021European Journal of Cancer8 citations Open access
Semantic Scholar
BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
L. Cortesi, F. Domati, A. Guida, I. Marchi +7 more
2021Cancer Biology and Medicine8 citations Open access
Semantic Scholar
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
M. Cox, Marta Banchi, S. Pelliccia, A. di Napoli +7 more
2020Cancer Chemotherapy and Pharmacology8 citations Open access
Semantic Scholar
Biological features and outcome of diffuse large B‐cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective ‘Elderly Project’ by the Fondazione Italiana Linfomi
A. Arcari, V. Tabanelli, F. Merli, L. Marcheselli +21 more
2023British Journal of Haematology7 citations
Semantic Scholar
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas.
Michele Merli, E. Genuardi, S. Zibellini, S. Rattotti +27 more
2026New England Journal of Medicine6 citations
Semantic Scholar
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
E. Iannitto, Simone Ferrero, C. Bommier, D. Drandi +28 more
2024Haematologica6 citations Open access
Semantic Scholar
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial
L. Guerra, S. Chauvie, F. Fallanca, F. Bergesio +33 more
2024European Journal of Nuclear Medicine and Molecular Imaging6 citations Open access
Semantic Scholar
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis
R. Marcheselli, A. Franceschetto, S. Sacchi, A. Bari +11 more
2019Leukemia and Lymphoma6 citations Open access
Semantic Scholar
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the FOLL12 Trial
R. Durmo, S. Chauvie, C. Minoia, F. Bergesio +29 more
2025American journal of hematology/oncology5 citations Open access
Semantic Scholar
Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study
A. Bavieri, S. Usai, Michele Merli, A. Di Rocco +26 more
2025Hematological Oncology4 citations
Semantic Scholar
Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study.
L. Cortesi, Giulia Cortesi, M. Venturelli, L. Marcheselli +10 more
2024European Journal of Surgical Oncology4 citations Open access
Semantic Scholar
Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)
M. Ferrante, D. Drandi, S. Zibellini, L. Marcheselli +26 more
2023Blood4 citations Open access
Semantic Scholar
RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
S. Luminari, S. Galimberti, A. Versari, A. Tucci +24 more
2021Hematological Oncology4 citations
Semantic Scholar
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
R. Durmo, S. Chauvie, F. Fallanca, F. Bergesio +20 more
2025Blood Advances3 citations
Semantic Scholar
A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial
M. Ladetto, S. Ferrero, I. Del Giudice, S. Galimberti +28 more
2021Blood3 citations Open access
Semantic Scholar
Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
N. Maher, Riccardo Moia, M. Almasri, L. Cividini +37 more
2026HemaSphere2 citations Open access
Semantic Scholar
Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study
L. Arcaini, M. Merli, S. Rattotti, M. Nizzoli +22 more
2026British Journal of Haematology2 citations Open access
Semantic Scholar
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE‐FIRST study
F. Quaglia, A. Arcari, Lucia Morello, L. Marcheselli +27 more
2025HemaSphere2 citations Open access
Semantic Scholar
Copanlisib in combination with rituximab and bendamustine for transplant‐ineligible relapsed/refractory diffuse large B‐cell lymphoma patients: Results from the phase II multicentre FIL Copa‐BR trial from Fondazione Italiana Linfomi (FIL)
M. Novo, P. M. M. Frascione, A. Castellino, L. Marcheselli +21 more
2025British Journal of Haematology2 citations Open access
Semantic Scholar
Impact of Minimal Residual Disease Analysis in the Era of Rituximab Maintenance in Follicular Lymphoma: Data from “FOLL12” Phase III Trial of the Fondazione Italiana Linfomi
Simone Ferrero, I. Del Giudice, S. Galimberti, V. Gattei +38 more
2024Blood2 citations
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
S. Luminari, C. Bommier, N. Fabbri, M. Nizzoli +27 more
2023Hematological Oncology2 citations Open access
Semantic Scholar
Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL)
S. Luminari, M. Nizzoli, A. Chiarenza, D. Mannina +25 more
2021Blood2 citations Open access
Semantic Scholar
A Simplified Geriatric Assessment (sGA) Can Identify Older Patients with Relapse/Refractory (R/R) Aggressive Lymphoma Suitable for Autologous Stem Cell Transplantation (ASCT): Final Results of Recanz Multicentre Prospective Phase 2 Study By the Fondazione Italiana Linfomi (FIL)
A. Tucci, G. Musuraca, F. Cavallo, V. Zilioli +16 more
2021Blood2 citations Open access
Semantic Scholar
Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma
Fulvio Massaro, Y. Stepanishyna, M. Manni, S. Luminari +9 more
2020British Journal of Haematology2 citations Open access
Semantic Scholar
Second-line chemotherapy in advanced biliary tract cancer: Who may benefit?
M. Salati, F. Caputo, L. Marcheselli, M. Rimini +8 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Long term follow up of the response adapted FOLL12 trial for patients with advanced stage follicular lymphoma: A study by the fondazione italiana linfomi (FIL).
M. Nizzoli, A. Anastasia, C. Boccomini, J. Olivieri +25 more
2025Blood1 citations
Semantic Scholar
Mosunetuzumab in combination with zanubrutinib is safe in patients with relapsed/refractory follicular lymphoma: Safety run-in results from the FIL-mozart Phase II study
Rita Tavarozzi, M. Ladetto, F. Bonello, Umberto Vitolo +6 more
2025Blood1 citations
Semantic Scholar
TP53 mutations in paired bone marrow and cell-free DNA samples of patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL_biowm study of fondazione italiana linfomi
M. Varettoni, S. Zibellini, D. Drandi, C. Varraso +23 more
2025Blood1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Arcari×19
Invite
A. Arcari — researcher profile on SciRah
S. Luminari×18
Invite
S. Luminari — researcher profile on SciRah
G. Gini×16
Invite
G. Gini — researcher profile on SciRah
V. Zilioli×15
Invite
V. Zilioli — researcher profile on SciRah

×14

Invite

M. Merli — researcher profile on SciRah

Invite

D. Mannina — researcher profile on SciRah

Invite

F. Merli — researcher profile on SciRah

Invite

E. Cencini — researcher profile on SciRah

G. Musuraca×12

Invite

G. Musuraca — researcher profile on SciRah

Invite

A. Tucci — researcher profile on SciRah

Invite

S. Usai — researcher profile on SciRah

Invite

L. Arcaini — researcher profile on SciRah